Alexander Tenenbaum
Alexander Tenenbaum (Sackler Faculty of Medicine, Tel-Aviv University)[1] is an Israeli medical doctor, university professor, and researcher in the fields of cardiology and diabetes.
Alexander Tenenbaum | |
|---|---|
 | |
| Born | Alexander Tenenbaum 1956 Frunze |
| Other names | Professor Alexander Tenenbaum |
Education and professional work
Tenenbaum was born in Frunze, former Soviet Union, in 1956. This is where he graduated with a medical degree in 1978. He received a PhD in 1986. Tenenbaum’s research was in the areas of high-altitude medicine[2] heart failure[3] and pulmonary hypertension.[4]
Tenenbaum immigrated to Israel in 1989. He started his work at Sheba Medical Center. During the next twenty years he held several different jobs at this hospital. These included residency in cardiology at the Heart Institute. He was also responsible for the Echocardiography Laboratory at the Cardiac Rehabilitation Institute. In 2003 he was appointed Deputy Director of the institute. Currently he is Scientific Director at the same institute.[5]
Further scientific investigations
Tenenbaum is author or coauthor of about 200 scientific publications. Most of them are original research articles published in critically peer-reviewed renowned medical journals. His research covers echocardiography,[6] cardiac CT,[7] heart failure,[8] cardiac calcification[9] and cardiac rehabilitation.[10] Tenenbaum was especially involved in the research of various aspects of metabolic syndrome,[11] insulin resistance,[12] obesity[13] and the diabetes/cardiovascular interrelationship including residual risk concept.[14]
Cardiovascular diabetology
As a result of the efforts of Dr. Tenenbaum and his colleagues from many countries, a strong correlation between cardiovascular disease and diabetes was established . A new branch of medicine, cardiovascular diabetology, was set up.[15] In 2002 Tenenbaum and Prof. Fisman founded an international scientific journal named Cardiovascular Diabetology (BioMed Central, Springer Sciences Media Group, London). It was dedicated to all aspects of the diabetes/cardiovascular interrelationship.[16] Cardiovascular Diabetology now is the world’s foremost journal specifically devoted to this issue. It has the highest Impact Factor among journals of similar field. Tenenbaum serves as Co-Editor-in-Chief of Cardiovascular Diabetology.
Academic appointments
In 2006, he was nominated Professor of Cardiology at Sackler Faculty of Medicine, Tel Aviv University.
Besides his accomplishments as an investigator, Dr. Tenenbaum has had a distinguished contribution as a medical educator both for Israeli and foreign students and cardiologists. He has organized the program for Continuous Medical Education of cardiologists from the former Soviet Union.
Activity in professional societies and awards
Tenenbaum worked for the advancement of the Israel Heart Society and international organizations of cardiologists. He was Governor of The International Society of Cardiovascular Pharmacotherapy,[17] Co-founder and Chairman of the Israeli Heart Society Working Group on Cardiovascular Pharmacology and Drug Therapy[18] and Co-founder and Secretary General of the Cardiovascular Diabetology Research Foundation.
Tenenbaum received many international and Israeli scientific awards. They include the Jan J. Kellermann Award and the Henry Neufeld Prize.
References
- ↑ FACULTY OF MEDICINE. Retrieved 6 December 2014.
- ↑ Mirrakhimov, M. M.. Syndrome of high-altitude hypertrophic cardiomyopathy.. Terapevticheskii Arkhiv 57 (4) (1985). p. 48–52.
- ↑ Mirrakhimov, M. M.. Noninvasive assessment of the function of the lesser circulation and of the right heart in mitral stenosis. Kardiologiia 27 (12) (1987). p. 45–48.
- ↑ Mirrakhimov, M. M.. New approaches to noninvasive assessment of pulmonary artery pressure. Clinical Cardiology 15 (11) (1992). p. 811–816. doi:10.1002/clc.4960151105.
- ↑ Prof Alexander TenenbaumCardiab. Retrieved 6 December 2014.
- ↑ Tenenbaum, A.. Improved posterobasal segment function after thrombolysis is associated with decreased incidence of significant mitral regurgitation in a first inferior myocardial infarction. Journal of the American College of Cardiology 25 (7) (1995). p. 1558–1563. doi:10.1016/0735-1097(95)00041-2.
- ↑ Tenenbaum, A.. Dual-helical CT for detecting aortic atheromas as a source of stroke: comparison with transesophageal echocardiography. Radiology 208 (1) (1998). p. 153–158. doi:10.1148/radiology.208.1.9646807.
- ↑ Tenenbaum, A.. Functional class in patients with heart failure is associated with the development of diabetes. The American Journal of Medicine 114 (4) (2003). p. 271–275. doi:10.1016/s0002-9343(02)01530-9.
- ↑ Tenenbaum, A.. Gender paradox in cardiac calcium deposits in middle-aged and elderly patients: mitral annular and coronary calcifications interrelationship. Maturitas 36 (1) (2000). p. 35–42. doi:10.1016/s0378-5122(00)00120-1.
- ↑ Tenenbaum, A.. Long-term versus intermediate-term supervised exercise training in advanced heart failure: effects on exercise tolerance and mortality. International Journal of Cardiology 113 (3) (2006). p. 364–370. doi:10.1016/j.ijcard.2005.11.098.
- ↑ Tenenbaum, A.. Macrovascular complications of metabolic syndrome: an early intervention is imperative. International Journal of Cardiology 97 (2) (2004). p. 167–172. doi:10.1016/j.ijcard.2003.07.033.
- ↑ Tenenbaum, A.. Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate. Archives of Internal Medicine 166 (7) (2006). p. 737–741. doi:10.1001/archinte.166.7.737.
- ↑ Tenenbaum, A.. Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients. European Heart Journal 26 (19) (2005). p. 2032–2038. doi:10.1093/eurheartj/ehi310.
- ↑ Tenenbaum, A.. Hypertension in diet versus pharmacologically treated diabetics: mortality over a 5-year follow-up. Hypertension (Dallas, Tex. : 1979) 33 (4) (1999). p. 1002–1007. doi:10.1161/01.hyp.33.4.1002.
- ↑ Cardiovascular Diabetology: Clinical, Metabolic and Inflammatory FacetsKarger. Retrieved 6 December 2014.
- ↑ Editors in ChiefCardiab. Retrieved 6 December 2014.
- ↑ Editorial Board | Cardiovascular Diabetology.
- ↑ Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosisThe Cardiovascular Drug Therapy. Retrieved 6 December 2014.